Remove topic process-control
article thumbnail

Rapid pseudomonas aeruginosa detection method developed

European Pharmaceutical Review

In the paper, the author acknowledged that topical medicinal products require the absence of bacterial species such as P. In the control bottle, the colour stayed green,” Puscas explained. For example, the author shared that the procedure can be used in microbiological laboratories of various levels. aeruginosa.

Media 96
article thumbnail

11th Annual Pharmaceutical Microbiology Europe Conference

pharmaphorum

Harnessing Alternative Rapid Microbial Methods for a Successful Contamination Control Strategy. This conference will explore the most pressing topics in this thriving field, from the movement toward process automation and increased regulatory stringency, to the latest technologies in rapid microbiological testing methods and data integrity.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Exploring the gene therapy biomanufacturing landscape

European Pharmaceutical Review

What are the key topics you plan to cover during your session at CPHI Barcelona? I firmly believe that manufacturing plays a pivotal role in this endeavour, and I will delve into topics such as production system optimisation and the standardisation of chemistry, manufacturing, and control (CMC) processes.”

article thumbnail

US FDA approves Krystal Biotech’s Vyjuvek for DEB

Pharmaceutical Technology

Vyjuvek is a non-invasive, topical, re-dosable gene therapy that delivers functional human COL7A1 gene copies to offer wound healing. In the GEM-1/2 trial, repeat topical applications of Vyjuvek resulted in full-length cutaneous COL7 expression, durable wound closure and anchoring fibril assembly with minimal adverse events.

FDA 52
article thumbnail

SXSW 2023: Moving from NFTs to LSD

PM360

During the integration process, patients revisit those constellations or memory libraries that they built for themselves.” The therapeutic process is therefore developed around the altered state of consciousness experience, rather than around a talk therapy framework.

Media 119
article thumbnail

AGC and RoosterBio partner for cell and exosome therapy manufacturing

Pharmaceutical Technology

The alliance will merge the cell and media products and process development services of RoosterBio with the worldwide cell and gene therapy manufacturing expertise of AGC. . To create strong and scalable processes for hMSC and exosome therapies, RoosterBio will leverage its broad-ranging cell and media product portfolio.

article thumbnail

Merck and Synplogen to develop viral vector gene therapies

Pharmaceutical Technology

This platform will aid Synplogen in boosting the speed of clinical manufacturing while lowering process development duration and expenses. As per the collaboration, Merck will provide technical support, training and process development and streamlining to Synplogen’s scientists at its M Lab Collaboration Center located in Tokyo, Japan.